AstraZeneca: Navigating Challenges Across Geographies Well
…
78,250€
0,32%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
IEFA Is a Great Choice for Most, but I Like VEA ETF Better
For investors in the United States, its pretty easy to get overexposed to domestic stocks. These are the brands that…
EQS-News: Attraktive Investmentperspektive: AstraZeneca zeigt Interesse an KI-Onkologie-Konsortium "PROmAI" (deutsch)
Attraktive Investmentperspektive: AstraZeneca zeigt Interesse an KI-Onkologie-Konsortium "PROmAI"^EQS-Media / 28.06.2025 / 14:56 CET/CESTOnco-Innovations Ltd. (ISIN: CA68237C1059 / WKN: A3EKSZ), Onco…
3 No-Brainer Stocks to Buy for Under $100 Right Now
Whats the biggest misconception about investing? The idea that you need a lot of money to get started is certainly…
EQS-News: Onco-Innovations begrüßt das Interesse von AstraZeneca an einer Gründungsrolle in PROmAI, einem von Inka angeführten KI-Onkologie-Konsortium (deutsch)
Onco-Innovations begrüßt das Interesse von AstraZeneca an einer Gründungsrolle in PROmAI, einem von Inka angeführten KI-Onkologie-Konsortium^Emittent / Herausgeber: MCS Market…
Onco-Innovations begrüßt das Interesse von AstraZeneca an einer Gründungsrolle in PROmAI, einem von Inka angeführten KI-Onkologie-Konsortium
Vancouver, Kanada - 27. Juni 2025 / IRW-Press / Onco-Innovations Limited (CBOE CA: ONCO) (Frankfurt: W1H, WKN: A3EKSZ) ("Onco" oder…
IRW-News: Onco-Innovations Limited: Onco-Innovations begrüßt das Interesse von AstraZeneca an einer Gründungsrolle in PROmAI, einem von Inka angeführten KI-Onkologie-Konsortium
IRW-PRESS: Onco-Innovations Limited: Onco-Innovations begrüßt das Interesse von AstraZeneca an einer Gründungsrolle in PROmAI, einem von Inka angeführten KI-Onkologie-KonsortiumVancouver, Kanada…
Is Astrazeneca (AZN) a Buy as Wall Street Analysts Look Optimistic?
The average brokerage recommendation (ABR) for Astrazeneca (AZN) is equivalent to a Buy. The overly optimistic recommendations of Wall Street…
FDA Grants Label Expansion to AstraZenecas Datroway in Lung Cancer
FDA expands AstraZenecas Datroway label, making it the first TROP2-directed lung cancer therapy approved in the United States.…
Why Astrazeneca (AZN) is a Top Value Stock for the Long-Term
Whether youre a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top…
Why Astrazeneca (AZN) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.…
3 Artificial Intelligence (AI) Stocks That Could Make You a Millionaire
If youre looking for stocks that have the potential to make you a millionaire on a relatively modest investment, youre…
Targeted cancer drugs may replace chemo for some patients — and drugmakers say theyre getting closer
Companies like AstraZeneca, Daiichi Sankyo, Pfizer and Merck are learning from previous setbacks in the ADC space to improve their…
Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know
Astrazeneca (AZN) concluded the recent trading session at $73.55, signifying a -1.17% move from its prior days close.…
AstraZeneca enters into collaboration with CSPC
13 June 2025
AstraZeneca enters strategic collaboration with CSPC Pharmaceuticals focused on AI-enabled research
AstraZeneca has entered a strategic research collaboration with…